Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 885-888

  Julian Reynier, Claire ^a   Eisinger, François ^a,b   Chabal, François ^a   Aurran, Yvette ^a   Bignon, Yves Jean ^c   Noguès, Catherine ^d   Machelard, Martine ^e   Maugard, Christine ^f   Vennin, Philippe ^g   Sobol, Hagay ^b  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c CENTRE JEAN PERRIN   (France)

^d CENTRE RENÉ HUGUENIN   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f CENTRE RENÉ GAUDUCHEAU   (France)

^g CENTRE OSCAR LAMBRET   (France)

Author keywords

Anxiety; Breast cancer; Cancer genetics; Depression; Evaluation; Family risk; Psycho social epidemiology

Indexed keywords

ADULT; ANTICIPATION; ANXIETY; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PATIENT; CONSULTATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; STRESS; TIME;

EID: 13144276270     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.885     Document Type: Article

References (28)

1. Houlston RS, Murday V, Harocopos C, Williams CB and Slack J: Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ 301: 366-368, 1990.
2. Sobol H, Bignon YJ, Cuisenier J, Lyonnet D, Nogues C and Eisinger F: Et le groupe génétique et cancer de la FNCLCC. Les consultations d'oncogénetique en 1994, analyse de l'activité: enquête sur 203 consultations. Eurocancer 95: 43-46, 1995.
3. Thompson JA, Wiesner GL, Sellers TA, Vachon C, Ahrens M, Potter JD, Sumpmann M and Kersey J: Genetic services for familial cancer patients: a survey of National Cancer Institute Cancer Centers. J Natl Cancer Inst 87: 1446-1455, 1995.
4. Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E and Varricchio C: Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 277: 997-1003, 1997.
5. Expertise collective INSERM-FNCLCC: Risques héréditaires de cancer du sein et de l'ovaire: quelle prise en charge. INSERM/FNCLCC, Paris, pp630, 1998.
6. Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Noguès C, Bignon Y-J, Machelard-Roumagnac C, Maugard-Louboutin C, Serin D, Blanc B, Orsoni P and Sobol H: Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 33: 731-736, 1996.
7. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G and Lynch H: BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275: 1885-1892, 1996.
8. Lynch HT, Fusaro RM, Lemon SJ, Smyrk T and Lynch J: Survey of cancer genetics genetic testing implications. Cancer 80: 523-532, 1997.
9. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YJ, Noguès C, Vennin P, Bignon YJ, Machelard M, Maugard C and Sobol H: Cancer genetic clinics: why do cancer patients attend? Eur J Cancer (In press).
10. Spielberger C: Assessment of state and trait anxiety: conceptual and methodological issues. Southern Psychol 2: 6-16, 1985.
11. Bruchon-Schweitzer ML and Paulhan I: Inventaire d'anxiété état-trait-Forme Y de Spielberger. Adaptation française. Editions du Centre de Psychologie Appliquée, 1993.
12. Gauthier J and Bouchard S: Adaptation Canadienne-Française de la forme révisée du State Trait Anxiety Inventory de Spielberger. Revue Canadienne des Sciences du Comportement 25: 559-589, 1993.
13. Fuhrer R and Rouillon F: La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'́chelle d'autoevaluation. Psychiatr Psychobiol 4: 163-166, 1989.
14. Moyer A: Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol 16: 284-298, 1997.
15. Spiegel D: Cancer and depression. Br J Psychiatry 168: 109-116, 1996.
16. Bartmann JA and Roberto KA: Coping strategies of middleaged and older women who have undergone a mastectomy. J Appl Gerontol 15: 376-386, 1996.
17. Rodrigue J, Behen JM and Tumlin T: Multidimensional determinants of psychological adjustment to cancer. Psychol Oncol 3: 205-214, 1994.
18. McDaniel JS, Musselman DL, Porter MR, Reed DA and Nemeroff CB: Depression in patients with cancer. Arch Gen Psychiatry 52: 89-99, 1995.
19. Costa D and Toma T: Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 72: 85-92, 1985.
20. Trijsburg RW, van Knippenberg FCE and Rijpma SE: Effects of psychology treatment on cancer patients: a critical review. Psychosom Med 54: 489-517, 1992.
21. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YJ, Noguès C, Vennin P, Bignon YJ, Machelard M, Maugard C and Sobol H: Cancer genetic clinics and anxiety in healthy consultees. Psychol Health (In press).
22. Holland JC and Rowland JH: Handbook of Psychooncology, Psychological Care of the Patient with Cancer. Oxford University Press, Oxford, 1990.
23. Razavi D and Delvaux N: Psycho-Oncologie. Massen, Paris, 1994.
24. Weinman AD: A model for psychosocial phasing in cancer. Gen Hosp Psychiatry 3: 187-195, 1979.
25. Eisinger F, Bignon YJ, Cuisenier J, Lyonnet D, Noguès C and Sobol H: Groupe génétique de la FNCLCC. Consultation d'oncogenetique: quelques recommandations du groupe génétique et cancer de la FNCLCC. Eurocancer 95: 47-49, 1995.
26. Jacquemier J, Stoppa-Lyonnet D, Guinebretiere JM, Bressac-de Paillerets B, Peyrat JP, Longy M, Eisinger F, Birnbaum D and Sobol H: Are hereditary breast cancer high risk tumors? A morphological analysis of BRCA1-associated breast cancers. Eurocancer 97: 9-11, 1997.
27. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349: 1505-1510, 1997.
28. Karp SE, Tonin PN, Begin LR, Martinez JJ, Zhang JC, Pollak MN and Foulkes WD: Influence of BRCA1 mutations on nuclear grade andestrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80: 435-441, 1997.